Jagsonpal Pharmaceuticals has signed a Business Transfer Agreement to acquire the India business of Resilient Cosmeceuticals for a cash consideration of Rs 24 crore, to be funded from internal accruals. The company had a cash balance of Rs 132 crore as on December 31, 2024.
The transaction is subject to customary closing conditions and is expected to close within 45 days. The acquisition gives access to a complimentary portfolio of Pharmaceuticals, Nutritional and Cosmetic products tapping into around Rs 1000 crore market opportunity in India.
Jagsonpal Pharmaceuticals is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities.
